Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET

摘要

Background. Hypertension is a risk factor for the two leading causes of death in renal transplant recipients: cardiovascular disease (CVD) and graft failure. Despite this, the optimum medication for post-transplant hypertension is unclear.